TABLE 2.
Variable | Hazard ratio | 95% CI | P a |
---|---|---|---|
Age (per 5 yrs) | 1.23 | 1.12–1.35 | <0.001* |
Female sex | 1.32 | 0.90–1.95 | 0.16 |
No. of coexisting conditions | 1.17 | 1.01–1.37 | 0.046* |
Obesity | 0.84 | 0.52–1.35 | 0.47 |
Active malignant disease | 1.76 | 1.01–3.09 | 0.048* |
Solid-organ transplantation | 1.60 | 0.78–3.28 | 0.20 |
Cardiovascular disease | 1.48 | 1.02–2.15 | 0.039* |
Structural lung disease | 1.23 | 0.78–1.94 | 0.38 |
Diabetes mellitus | 1.12 | 0.73–1.71 | 0.60 |
History of smoking | 0.75 | 0.38–1.49 | 0.41 |
ECMO | 1.04 | 0.51–2.14 | 0.91 |
Invasive mechanical ventilation | 0.68 | 0.46–1.02 | 0.062 |
Noninvasive ventilation | 0.75 | 0.51–1.10 | 0.14 |
Results of BALF mycological tests | 0.28 | ||
Negative BALF GM and negative BALF culture | Reference | ||
Positive BALF GM and negative BALF culture | 1.05 | 0.54–2.04 | 0.87 |
Negative BALF GM and positive BALF culture | 1.38 | 0.43–4.39 | 0.59 |
Positive BALF GM and positive BALF culture | 1.72 | 1.02–2.92 | 0.043* |
*, P < 0.05.